Among patients with who were newly diagnosed polycythemia vera (PV), treatment with Jakafi (ruxolitinib) and low-dose Pegasys (pegylated interferon alfa-2a) was found to be beneficial, resulting in ...

However, results of clinical trials with interferon, and the expected effects ... cumulative rate for PV, ET and PMF was 2.1 per 100,000. [8] Furthermore, owing to their relatively smooth clinical ...